Recovering scientist turned early stage VC A biotech optimist fighting gravity

You Want To Be A CBO? Four Tips To Set You On Your Way
May 3, 2021

By Deanna Petersen, Chief Business Officer of AVROBIO, as part of the From The Trenches feature of LifeSciVC Most of the titles in a biotech C-suite are generally self-explanatory. The Chief Technical and Manufacturing Officer runs operations in CMC and

Leave a comment

The Unsung Heroes Of Entrepreneurial Companies
April 26, 2021

The role of the core in making an organization great and how we do right by them By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC Small organizations are amazing for the

Leave a comment

Five Macro Risks To Biotech Coming Out of Washington
April 22, 2021

Despite saving the world from COVID, pharma and biotech are still in the crosshairs of many politicians. With many anti-Pharma politicians and regulators emboldened in the current environment, and with more aggressive tax and spending policy in the works, there

Leave a comment

Biotech Funding Tops The Charts Again
April 20, 2021

Another quarter, another set of all-time highs for biotech funding – and this surfeit of capital continues raises possible concerns about its disciplined deployment. Back in January, when reflecting on the strange paradox of 2020, all-time-highs were across the board:

Leave a comment

Reimagining The Workplace Post Pandemic
April 15, 2021

By Jonathan Montagu, CEO of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC Returning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace.  CEO’s that I have spoken

Leave a comment

Scaling Culture With Growth: How to maintain your startup’s “special sauce”
April 8, 2021

By Joshua Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC I’ve been thinking a lot about growth, and for good reason: Dyne is in the midst of a significant scale-up. We expanded our

Leave a comment

Ode to Scientists
April 1, 2021

By Samantha Truex, CEO of Quench Bio, as part of the From The Trenches feature of LifeSciVC In the fall of 2019, I wrote a blog called Ode to Patients.  As stresses from many directions have mounted over the past

Leave a comment

Strategy Sync vs. Time Sink with Your Board
March 25, 2021

By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC.  If we could quantify the time and money impact of the resources invested in quarterly Board meeting preparation, I wonder if we would

Leave a comment

Selective Allosteric TYK2 Inhibitors
March 18, 2021

Family Oddball, and a New Class of Safe Oral Autoimmune & Inflammatory Disease Treatment with Blockbuster Potential By Jeb Keiper, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC. On day one of the JPM

Leave a comment

Personal Reflection: Empathy In The Workplace
March 16, 2021

Just before I chaired a Board meeting last year, I spent a frustratingly painful hour going through many of the uncomfortable details of my divorce process and a set of emotional custody issues with my lawyers. Immediately after hanging up,

Leave a comment

A Firsthand Covid Perspective
January 8, 2021

By Jeb Keiper, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC. This blog is dedicated to the front-line healthcare workers, essential service workers, scientists, patients, and their families who confront COVID-19 every day, and

Leave a comment

The Biotech Paradox of 2020: A Year In Review
January 4, 2021

2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism. It was truly a horrifically tragic year for humanity, and for America in particular.  As everyone knows,

Leave a comment